Encouraging new treatment for dementia is emerging

Some of my friends email me or post to me on Facebook when they see a science article talking about Alzheimer's or dementia, as everyone knows this is the cause nearest to my heart.  I do read them all.  Some I just shrug and say "yeah maybe" or "you wish" but this one...well, this one seems promising. I'll let the first paragraph of the article speak for itself: The first experimental drug to boost brain synapses lost in Alzheimer’s disease has been developed by researchers at Sanford-Burnham. The drug, called NitroMemantine, combines two FDA-approved medicines to stop the destructive cascade of changes in the brain that destroys the connections between neurons, leading to memory loss and cognitive decline. To me, that means that they shouldn't have to get FDA approval, right?  This could be an off-label usage?  I'm trying to understand how the drugs are being combined.  I'm thinking of PhenFen, that diet drug that was two other drugs combined. (And it ended up killing people, didn't it? Maybe that's a bad example...) The decade-long study...shows that NitroMemantine can restore synapses, representing the connections between nerve cells (neurons) that have been lost during the progression of Alzheimer’s in the brain. That's A LOT to promise.   And they aren't done promising yet.  They are abandoing the old method of looking at the "amyloid beta plaques and neurofibrillary tangles" (what the drug my dad tested was looking at) in fav...
Source: Had a Dad Alzheimers Blog - Category: Dementia Authors: Source Type: blogs